Results 161 to 170 of about 24,887 (213)

Preoperative medical therapy for acromegaly: current knowledge and clinical significance. [PDF]

Front Endocrinol (Lausanne)
He D, Wang Q, Sheng Z, Li G.
europepmc   +1 more source

DNA Repair Enzyme Regulation Strategy for Enhanced Pancreatic Neuroendocrine Tumor Therapy via Targeting siRNA-Lipid Nanoparticles. [PDF]

ACS Nano
Wang F, Li Y, Xu J, Tang W, Xu X, Lou X, Jing D, Fan G, Qin Y, Chen J, Yu X, Cai W, Tang Z, Ji S.   +13 more
europepmc   +1 more source

Functional profiling of somatostatin receptors identifies somatostatin receptor subtype 2 as a vulnerability in Succinate Dehydrogenase SDHB-deficient pheochromocytomas and paragangliomas. [PDF]

Mol Biomed
García-Vioque V, Pedraza-Arevalo S, Moreno-Montilla MT, Rivero-Cortés E, Blázquez-Encinas R, Mangili F, Arroba E, Herrera-Martínez AD, Culler MD, Gálvez-Moreno MÁ, Barlier A, Botella LM, Robledo M, Castaño JP, Ibáñez-Costa A.   +14 more
europepmc   +1 more source

Comparison of Lanreotide and Octreotide LAR Use and Outcomes for Gastrointestinal Neuroendocrine Tumors in British Columbia, Canada. [PDF]

Cancer Control
Paul A, Mendis S, Diaz-Stewart M, Jao J, Boutin M, Safro M, Denault MH, Speers C, Stuart H, Gill S, Renouf DJ, Schaeffer DF, Farnell D, Loree JM.   +13 more
europepmc   +1 more source

Non-surgical management of malignant bowel obstruction: strategies and outcomes in inoperable patients. [PDF]

J Gastrointest Oncol
Escobar Gil T, Viswanath P, Rosenberg S, Quazi MA, Hanson V, Ortega Macias A, Tarnower A.   +6 more
europepmc   +1 more source

Navigating chylous pericardial effusion: a case study and evidence-based review of management options. [PDF]

J Cardiothorac Surg
Phey ZYD, Lizwan M, Chia CML.
europepmc   +1 more source

Symptom management with osilodrostat in multiple endocrine neoplasia type 1 with a Cushing syndrome presentation. [PDF]

JCEM Case Rep
Jamal HF.
europepmc   +1 more source

Ectopic Olfactory Neuroblastoma of the Maxillary Sinus: A Case Report. [PDF]

Clin Case Rep
Jahandideh H, Yadmehr F, Abrishami M.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Octreotide and Octreotide-derived delivery systems

Journal of Drug Targeting, 2023
Pharmaceutical peptide Octreotide is a somatostatin analog with targeting and therapeutic abilities. Over the last decades, Octreotide has been developed and approved to treat acromegaly and neuroendocrine tumours, and Octreotide-based radioactive conjugates have been leveraged clinically to detect small neuroendocrine tumour sites.
Xinlin Zhu
exaly   +3 more sources